Skip to main content

SB 212 — Kansas

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Failed / died 2025-2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • SB 212 is a bill in the Kansas Senate, 2025-2026 session, introduced February 5, 2025.
  • Sponsored by Dinah Sykes.
  • Current status: failed / died.
  • Most recent action (April 10, 2026): Died in Committee.
  • Subjects: Insurance, Named Acts, Pharmacists and Pharmacy.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Dinah Sykes

History

  1. Introduced, completed
  2. Passed Senate (stopped), where this bill stopped
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Introduced Milestone
  2. Senate Referred to Senate Committee on Financial Institutions and Insurance
  3. Senate Died in Committee Milestone Latest

Source: Open States. Last checked November 17, 2026. How we keep this accurate ›